NOVELIX PHARMACEUTICALS LIMITED: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Sep-20 | Dec-20 | Mar-21 | Jun-21 | Sep-21 | Dec-21 | Jun-22 | Sep-22 |
|---|---|---|---|---|---|---|---|---|
| 2 | 2 | 3 | 4 | 2 | 1 | 1 | 1 | |
| 0.07 | 0.11 | 0.05 | 0.10 | 0.30 | 0.07 | 0.06 | 0.06 | |
| 3 | 2 | 3 | 4 | 3 | 1 | −0.11 | 1 | |
| 3 | 3 | 6 | 5 | 2 | 2 | 2 | 1 | |
| 0.56 | 0.50 | 0.49 | 0.30 | 0.05 | 0.07 | 0.11 | 0.04 | |
| 1 | 1 | 2 | 4 | 2 | 0.96 | 1 | 1 | |
| 0.06 | 0.02 | −0.10 | −0.86 | −0.05 | 0.34 | — | 0.01 | |
| 0.29 | 0.25 | 0.23 | 0.20 | 0.15 | 0.16 | 0.14 | 0.20 | |
| 0.02 | 0.01 | 0.01 | — | — | — | — | — | |
| 0.02 | 0.08 | 0.06 | 0.05 | 0.04 | 0.04 | 0.02 | 0.02 | |
| 0.57 | 0.47 | 4 | 0.45 | 0.31 | 0.51 | 0.14 | 0.11 | |
| −0.09 | −0.14 | −3 | −0.06 | 0.48 | −0.87 | −0.07 | −0.12 | |
| −0.11 | −0.22 | −3 | −0.11 | 0.44 | −0.91 | −0.09 | −0.14 | |
| −0.13 | −0.23 | −3 | −0.11 | 0.41 | −0.91 | 7 | −0.14 | |
| — | — | — | — | 0.03 | — | 0.02 | — | |
| −0.13 | −0.23 | −3 | −0.11 | 0.44 | −0.91 | −0.09 | −0.14 | |
| 0.03 | — | — | 0.03 | 0.09 | −0.21 | — | — | |
| −0.15 | −0.23 | −3 | −0.07 | 0.35 | −0.74 | −0.09 | −0.15 | |
| Financial ratios | ||||||||
| -3.63% | -6.39% | -127.49% | -1.38% | 19.51% | -78.38% | -5.15% | -9.68% | |
| -6.05% | -10.50% | -131.08% | -1.61% | 14.23% | -66.67% | -6.62% | -12.10% | |
| -0.21 | -0.26 | -4.05 | -0.18 | 0.39 | -0.77 | -0.11 | -0.19 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.